- Home
- INVA vs OPK Comparison
INVA vs OPK Comparison
Compare INVA & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INVA
- OPK
- Stock Information
- Founded
- INVA 1996
- OPK 2007
- Country
- INVA United States
- OPK United States
- Employees
- INVA N/A
- OPK N/A
- Industry
- INVA Biotechnology: Pharmaceutical Preparations
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- INVA Health Care
- OPK Health Care
- Exchange
- INVA Nasdaq
- OPK Nasdaq
- Market Cap
- INVA 1.2B
- OPK 1.0B
- IPO Year
- INVA 2004
- OPK 1995
- Fundamental
- Price
- INVA $20.17
- OPK $1.46
- Analyst Decision
- INVA Buy
- OPK Strong Buy
- Analyst Count
- INVA 1
- OPK 3
- Target Price
- INVA N/A
- OPK $2.75
- AVG Volume (30 Days)
- INVA 618.1K
- OPK 3.3M
- Earning Date
- INVA 10-30-2024
- OPK 11-04-2024
- Dividend Yield
- INVA N/A
- OPK N/A
- EPS Growth
- INVA N/A
- OPK N/A
- EPS
- INVA 2.05
- OPK N/A
- Revenue
- INVA $330,496,000.00
- OPK $716,372,000.00
- Revenue This Year
- INVA $11.25
- OPK N/A
- Revenue Next Year
- INVA $0.57
- OPK $1.36
- P/E Ratio
- INVA $9.86
- OPK N/A
- Revenue Growth
- INVA 13.80
- OPK N/A
- 52 Week Low
- INVA $12.22
- OPK $0.85
- 52 Week High
- INVA $20.37
- OPK $1.75
- Technical
- Relative Strength Index (RSI)
- INVA 65.25
- OPK 43.17
- Support Level
- INVA $19.79
- OPK $1.42
- Resistance Level
- INVA $20.02
- OPK $1.56
- Average True Range (ATR)
- INVA 0.36
- OPK 0.06
- MACD
- INVA 0.05
- OPK -0.00
- Stochastic Oscillator
- INVA 83.47
- OPK 25.00
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties and innovative healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.